Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TFAP2C
|
ENSG00000087510.5 | transcription factor AP-2 gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TFAP2C | hg19_v2_chr20_+_55205825_55205938 | -0.36 | 4.9e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51487282 | 2.56 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr19_-_51487071 | 2.28 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr13_-_20806440 | 2.12 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
chr19_+_35645817 | 2.05 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr10_-_5541525 | 1.84 |
ENST00000380332.3
|
CALML5
|
calmodulin-like 5 |
chr4_-_57522673 | 1.84 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr22_+_38071615 | 1.82 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
chr12_+_53491220 | 1.74 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
chr18_-_28681950 | 1.73 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
chr10_+_95256356 | 1.73 |
ENST00000371485.3
|
CEP55
|
centrosomal protein 55kDa |
chr4_-_57522598 | 1.69 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr1_-_153521597 | 1.65 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr6_+_151561506 | 1.65 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr1_-_153521714 | 1.65 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr9_+_131182697 | 1.59 |
ENST00000372838.4
ENST00000411852.1 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
chr9_+_139553306 | 1.51 |
ENST00000371699.1
|
EGFL7
|
EGF-like-domain, multiple 7 |
chr19_+_8429031 | 1.51 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
chr19_+_35645618 | 1.46 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr20_+_3776936 | 1.44 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
chr19_-_51512804 | 1.44 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
chr2_-_241396131 | 1.42 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
chr2_+_64681103 | 1.35 |
ENST00000464281.1
|
LGALSL
|
lectin, galactoside-binding-like |
chr7_+_100770328 | 1.35 |
ENST00000223095.4
ENST00000445463.2 |
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
chr19_-_51456198 | 1.32 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
chr22_-_37640277 | 1.29 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr6_-_105627735 | 1.26 |
ENST00000254765.3
|
POPDC3
|
popeye domain containing 3 |
chr12_+_27485889 | 1.25 |
ENST00000311001.5
ENST00000261178.5 ENST00000266503.5 |
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
chr8_+_86376081 | 1.23 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
chr6_+_151662815 | 1.21 |
ENST00000359755.5
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr2_-_31440377 | 1.19 |
ENST00000444918.2
ENST00000403897.3 |
CAPN14
|
calpain 14 |
chr4_-_56502426 | 1.18 |
ENST00000505262.1
ENST00000507338.1 |
NMU
|
neuromedin U |
chr20_-_43280325 | 1.16 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
chr10_+_88728189 | 1.14 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
chr8_-_23261589 | 1.13 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
chr3_-_48632593 | 1.13 |
ENST00000454817.1
ENST00000328333.8 |
COL7A1
|
collagen, type VII, alpha 1 |
chr13_+_110959598 | 1.12 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr2_+_64681219 | 1.12 |
ENST00000238875.5
|
LGALSL
|
lectin, galactoside-binding-like |
chr1_-_17304771 | 1.10 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chr9_+_116037922 | 1.10 |
ENST00000374198.4
|
PRPF4
|
pre-mRNA processing factor 4 |
chr20_-_23967432 | 1.09 |
ENST00000286890.4
ENST00000278765.4 |
GGTLC1
|
gamma-glutamyltransferase light chain 1 |
chr17_+_1945301 | 1.09 |
ENST00000572195.1
|
OVCA2
|
ovarian tumor suppressor candidate 2 |
chr22_-_37640456 | 1.08 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr20_-_56284816 | 1.07 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr10_+_17271266 | 1.06 |
ENST00000224237.5
|
VIM
|
vimentin |
chr22_-_37915247 | 1.06 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
chr2_-_241396106 | 1.05 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
chr6_+_34204642 | 1.02 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
chr2_-_216300784 | 1.01 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr10_+_75670862 | 1.01 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
chr20_-_52790512 | 1.01 |
ENST00000216862.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
chr20_-_43280361 | 1.00 |
ENST00000372874.4
|
ADA
|
adenosine deaminase |
chr6_+_151561085 | 1.00 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr1_-_205391178 | 1.00 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
chr9_+_140119618 | 1.00 |
ENST00000359069.2
|
C9orf169
|
chromosome 9 open reading frame 169 |
chr1_-_6321035 | 0.99 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
chr4_+_77172847 | 0.99 |
ENST00000515604.1
ENST00000539752.1 ENST00000424749.2 |
FAM47E
FAM47E-STBD1
FAM47E
|
uncharacterized protein LOC100631383 FAM47E-STBD1 readthrough family with sequence similarity 47, member E |
chr11_+_849816 | 0.98 |
ENST00000527644.1
|
TSPAN4
|
tetraspanin 4 |
chr22_-_37915535 | 0.98 |
ENST00000403299.1
|
CARD10
|
caspase recruitment domain family, member 10 |
chr14_-_35183755 | 0.98 |
ENST00000555765.1
|
CFL2
|
cofilin 2 (muscle) |
chr11_+_118826999 | 0.97 |
ENST00000264031.2
|
UPK2
|
uroplakin 2 |
chr19_-_43032532 | 0.96 |
ENST00000403461.1
ENST00000352591.5 ENST00000358394.3 ENST00000403444.3 ENST00000308072.4 ENST00000599389.1 ENST00000351134.3 ENST00000161559.6 |
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
chr18_+_33877654 | 0.96 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr4_-_56502451 | 0.96 |
ENST00000511469.1
ENST00000264218.3 |
NMU
|
neuromedin U |
chr8_+_124194875 | 0.96 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
chr12_+_27485785 | 0.96 |
ENST00000544915.1
|
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
chr12_-_125348329 | 0.94 |
ENST00000546215.1
ENST00000415380.2 ENST00000261693.6 ENST00000376788.1 ENST00000545493.1 |
SCARB1
|
scavenger receptor class B, member 1 |
chr16_-_4588762 | 0.94 |
ENST00000562334.1
ENST00000562579.1 ENST00000567695.1 ENST00000563507.1 |
CDIP1
|
cell death-inducing p53 target 1 |
chr19_-_51456344 | 0.94 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr12_-_48152853 | 0.94 |
ENST00000171000.4
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr19_-_51456321 | 0.93 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr12_-_124018252 | 0.93 |
ENST00000376874.4
|
RILPL1
|
Rab interacting lysosomal protein-like 1 |
chr1_-_6545502 | 0.93 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr17_+_1959369 | 0.92 |
ENST00000576444.1
ENST00000322941.3 |
HIC1
|
hypermethylated in cancer 1 |
chr17_-_39769005 | 0.92 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr10_+_124221036 | 0.92 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr1_+_17559776 | 0.92 |
ENST00000537499.1
ENST00000413717.2 ENST00000536552.1 |
PADI1
|
peptidyl arginine deiminase, type I |
chr6_-_160148356 | 0.92 |
ENST00000401980.3
ENST00000545162.1 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr4_-_987217 | 0.91 |
ENST00000361661.2
ENST00000398516.2 |
SLC26A1
|
solute carrier family 26 (anion exchanger), member 1 |
chr12_+_70760056 | 0.90 |
ENST00000258111.4
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr11_+_35160709 | 0.88 |
ENST00000415148.2
ENST00000433354.2 ENST00000449691.2 ENST00000437706.2 ENST00000360158.4 ENST00000428726.2 ENST00000526669.2 ENST00000433892.2 ENST00000278386.6 ENST00000434472.2 ENST00000352818.4 ENST00000442151.2 |
CD44
|
CD44 molecule (Indian blood group) |
chr19_+_45281118 | 0.87 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr9_-_123638633 | 0.87 |
ENST00000456291.1
|
PHF19
|
PHD finger protein 19 |
chr11_-_2193025 | 0.86 |
ENST00000333684.5
ENST00000381178.1 ENST00000381175.1 ENST00000352909.3 |
TH
|
tyrosine hydroxylase |
chr20_+_6748311 | 0.85 |
ENST00000378827.4
|
BMP2
|
bone morphogenetic protein 2 |
chr4_-_74864386 | 0.85 |
ENST00000296027.4
|
CXCL5
|
chemokine (C-X-C motif) ligand 5 |
chr19_+_6531010 | 0.85 |
ENST00000245817.3
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9 |
chr1_+_44401479 | 0.83 |
ENST00000438616.3
|
ARTN
|
artemin |
chr12_-_48152611 | 0.82 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr9_+_132099158 | 0.82 |
ENST00000444125.1
|
RP11-65J3.1
|
RP11-65J3.1 |
chr19_+_39279838 | 0.82 |
ENST00000314980.4
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B |
chr20_+_34203794 | 0.81 |
ENST00000374273.3
|
SPAG4
|
sperm associated antigen 4 |
chr19_+_41725088 | 0.81 |
ENST00000301178.4
|
AXL
|
AXL receptor tyrosine kinase |
chr12_-_53242770 | 0.81 |
ENST00000304620.4
ENST00000547110.1 |
KRT78
|
keratin 78 |
chr6_-_160147925 | 0.81 |
ENST00000535561.1
|
SOD2
|
superoxide dismutase 2, mitochondrial |
chr1_-_27286897 | 0.81 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
chr19_-_41859814 | 0.81 |
ENST00000221930.5
|
TGFB1
|
transforming growth factor, beta 1 |
chr17_-_1395954 | 0.81 |
ENST00000359786.5
|
MYO1C
|
myosin IC |
chr5_+_96211643 | 0.80 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr7_+_111846643 | 0.80 |
ENST00000361822.3
|
ZNF277
|
zinc finger protein 277 |
chr8_+_54793454 | 0.80 |
ENST00000276500.4
|
RGS20
|
regulator of G-protein signaling 20 |
chr15_-_64338521 | 0.79 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
chr17_+_74381343 | 0.79 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
chr9_+_139560197 | 0.78 |
ENST00000371698.3
|
EGFL7
|
EGF-like-domain, multiple 7 |
chr19_-_39264072 | 0.78 |
ENST00000599035.1
ENST00000378626.4 |
LGALS7
|
lectin, galactoside-binding, soluble, 7 |
chr2_-_1748214 | 0.78 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr19_+_54371114 | 0.77 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
chr11_+_72929402 | 0.77 |
ENST00000393596.2
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2 |
chr11_+_72929319 | 0.77 |
ENST00000393597.2
ENST00000311131.2 |
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2 |
chr19_-_19049791 | 0.77 |
ENST00000594439.1
ENST00000221222.11 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr10_-_25241499 | 0.77 |
ENST00000376378.1
ENST00000376376.3 ENST00000320152.6 |
PRTFDC1
|
phosphoribosyl transferase domain containing 1 |
chr15_-_70388943 | 0.77 |
ENST00000559048.1
ENST00000560939.1 ENST00000440567.3 ENST00000557907.1 ENST00000558379.1 ENST00000451782.2 ENST00000559929.1 |
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
chr19_-_1513188 | 0.77 |
ENST00000330475.4
|
ADAMTSL5
|
ADAMTS-like 5 |
chr1_-_109825751 | 0.76 |
ENST00000369907.3
ENST00000438534.2 ENST00000369909.2 ENST00000409138.2 |
PSRC1
|
proline/serine-rich coiled-coil 1 |
chr19_-_35992780 | 0.76 |
ENST00000593342.1
ENST00000601650.1 ENST00000408915.2 |
DMKN
|
dermokine |
chr20_+_361890 | 0.75 |
ENST00000449710.1
ENST00000422053.2 |
TRIB3
|
tribbles pseudokinase 3 |
chr15_-_70388599 | 0.75 |
ENST00000560996.1
ENST00000558201.1 |
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
chr9_-_22009241 | 0.75 |
ENST00000380142.4
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
chr16_-_4588822 | 0.75 |
ENST00000564828.1
|
CDIP1
|
cell death-inducing p53 target 1 |
chr11_+_69061594 | 0.75 |
ENST00000441339.2
ENST00000308946.3 ENST00000535407.1 |
MYEOV
|
myeloma overexpressed |
chr12_+_53443680 | 0.75 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr2_-_224903995 | 0.75 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr1_-_109825719 | 0.75 |
ENST00000369904.3
ENST00000369903.2 ENST00000429031.1 ENST00000418914.2 ENST00000409267.1 |
PSRC1
|
proline/serine-rich coiled-coil 1 |
chr20_-_10654639 | 0.74 |
ENST00000254958.5
|
JAG1
|
jagged 1 |
chr19_-_11689752 | 0.74 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr19_+_35783047 | 0.74 |
ENST00000595791.1
ENST00000597035.1 ENST00000537831.2 |
MAG
|
myelin associated glycoprotein |
chr2_-_235405168 | 0.74 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr6_+_151187074 | 0.73 |
ENST00000367308.4
|
MTHFD1L
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chr3_-_50340996 | 0.73 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr16_+_31483374 | 0.73 |
ENST00000394863.3
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
chr16_-_4588469 | 0.72 |
ENST00000588381.1
ENST00000563332.2 |
CDIP1
|
cell death-inducing p53 target 1 |
chr21_-_44495919 | 0.72 |
ENST00000398158.1
|
CBS
|
cystathionine-beta-synthase |
chr17_+_7942424 | 0.72 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr3_-_128712906 | 0.71 |
ENST00000511438.1
|
KIAA1257
|
KIAA1257 |
chr7_+_130131907 | 0.71 |
ENST00000223215.4
ENST00000437945.1 |
MEST
|
mesoderm specific transcript |
chr2_-_72375167 | 0.71 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr11_-_6341724 | 0.71 |
ENST00000530979.1
|
PRKCDBP
|
protein kinase C, delta binding protein |
chr1_-_9189229 | 0.71 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
chr4_+_4388805 | 0.71 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr17_+_74372662 | 0.71 |
ENST00000591651.1
ENST00000545180.1 |
SPHK1
|
sphingosine kinase 1 |
chr17_-_39637392 | 0.71 |
ENST00000246639.2
ENST00000393989.1 |
KRT35
|
keratin 35 |
chr19_-_49016418 | 0.71 |
ENST00000270238.3
|
LMTK3
|
lemur tyrosine kinase 3 |
chr4_+_7194247 | 0.71 |
ENST00000507866.2
|
SORCS2
|
sortilin-related VPS10 domain containing receptor 2 |
chr18_-_28682374 | 0.70 |
ENST00000280904.6
|
DSC2
|
desmocollin 2 |
chr11_-_2906979 | 0.70 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr9_+_125137565 | 0.69 |
ENST00000373698.5
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
chr15_-_74501360 | 0.69 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
chrX_-_153602991 | 0.69 |
ENST00000369850.3
ENST00000422373.1 |
FLNA
|
filamin A, alpha |
chr17_+_4402133 | 0.69 |
ENST00000329078.3
|
SPNS2
|
spinster homolog 2 (Drosophila) |
chr11_+_842928 | 0.69 |
ENST00000397408.1
|
TSPAN4
|
tetraspanin 4 |
chr19_-_19051103 | 0.68 |
ENST00000542541.2
ENST00000433218.2 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr12_-_57634475 | 0.68 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr9_+_128509663 | 0.68 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr11_+_68671310 | 0.68 |
ENST00000255078.3
ENST00000539224.1 |
IGHMBP2
|
immunoglobulin mu binding protein 2 |
chr1_-_6557441 | 0.67 |
ENST00000400915.3
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr12_+_6493319 | 0.67 |
ENST00000536876.1
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
chr12_+_53443963 | 0.67 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr12_-_28123206 | 0.67 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
chr3_-_52567792 | 0.67 |
ENST00000307092.4
ENST00000422318.2 ENST00000459839.1 |
NT5DC2
|
5'-nucleotidase domain containing 2 |
chr1_+_205473720 | 0.66 |
ENST00000429964.2
ENST00000506784.1 ENST00000360066.2 |
CDK18
|
cyclin-dependent kinase 18 |
chr14_-_23834411 | 0.66 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr5_-_157002775 | 0.66 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr7_+_99156011 | 0.66 |
ENST00000320583.5
ENST00000357864.2 |
ZNF655
|
zinc finger protein 655 |
chr8_+_22428457 | 0.66 |
ENST00000517962.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
chr8_+_54793425 | 0.65 |
ENST00000522225.1
|
RGS20
|
regulator of G-protein signaling 20 |
chr17_+_7942335 | 0.65 |
ENST00000380183.4
ENST00000572022.1 ENST00000380173.2 |
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr17_+_8339164 | 0.65 |
ENST00000582665.1
ENST00000334527.7 ENST00000299734.7 |
NDEL1
|
nudE neurodevelopment protein 1-like 1 |
chr10_+_11784360 | 0.65 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
chr21_-_32931290 | 0.65 |
ENST00000286827.3
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1 |
chr19_-_51522955 | 0.65 |
ENST00000358789.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr20_+_25228669 | 0.65 |
ENST00000216962.4
|
PYGB
|
phosphorylase, glycogen; brain |
chr1_+_45265897 | 0.65 |
ENST00000372201.4
|
PLK3
|
polo-like kinase 3 |
chr17_+_26662597 | 0.65 |
ENST00000544907.2
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr2_+_70142232 | 0.64 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
chr12_-_54813229 | 0.64 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
chr11_+_2920951 | 0.63 |
ENST00000347936.2
|
SLC22A18
|
solute carrier family 22, member 18 |
chr20_-_56285595 | 0.63 |
ENST00000395816.3
ENST00000347215.4 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr7_+_116165038 | 0.63 |
ENST00000393470.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr11_+_129245796 | 0.63 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
chr12_-_76425368 | 0.63 |
ENST00000602540.1
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1 |
chr18_-_28622774 | 0.62 |
ENST00000434452.1
|
DSC3
|
desmocollin 3 |
chr7_+_76139925 | 0.62 |
ENST00000394849.1
|
UPK3B
|
uroplakin 3B |
chrX_+_64887512 | 0.62 |
ENST00000360270.5
|
MSN
|
moesin |
chr16_+_2022036 | 0.62 |
ENST00000568546.1
|
TBL3
|
transducin (beta)-like 3 |
chr17_+_26662730 | 0.61 |
ENST00000226225.2
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr19_-_38397285 | 0.61 |
ENST00000303868.5
|
WDR87
|
WD repeat domain 87 |
chr11_-_66104237 | 0.61 |
ENST00000530056.1
|
RIN1
|
Ras and Rab interactor 1 |
chr14_-_106068065 | 0.61 |
ENST00000390541.2
|
IGHE
|
immunoglobulin heavy constant epsilon |
chr17_-_7493390 | 0.60 |
ENST00000538513.2
ENST00000570788.1 ENST00000250055.2 |
SOX15
|
SRY (sex determining region Y)-box 15 |
chr19_-_41934635 | 0.60 |
ENST00000321702.2
|
B3GNT8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
chr1_+_152956549 | 0.60 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
chr4_-_103266219 | 0.60 |
ENST00000394833.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr11_+_126276070 | 0.60 |
ENST00000449406.2
ENST00000532243.1 |
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
chr16_+_3194211 | 0.60 |
ENST00000428155.1
|
CASP16
|
caspase 16, apoptosis-related cysteine peptidase (putative) |
chr19_-_14629224 | 0.59 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr16_+_31483451 | 0.59 |
ENST00000565360.1
ENST00000361773.3 |
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
chr5_-_72744336 | 0.59 |
ENST00000499003.3
|
FOXD1
|
forkhead box D1 |
chr1_-_161519579 | 0.59 |
ENST00000426740.1
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr8_+_145734433 | 0.59 |
ENST00000301327.4
|
MFSD3
|
major facilitator superfamily domain containing 3 |
chr15_-_45815005 | 0.59 |
ENST00000261867.4
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4 |
chr9_+_132096166 | 0.59 |
ENST00000436710.1
|
RP11-65J3.1
|
RP11-65J3.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 8.0 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.2 | 3.5 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.8 | 2.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.7 | 2.2 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.7 | 2.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.6 | 2.3 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.5 | 0.5 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.5 | 1.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.5 | 0.9 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.5 | 1.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 1.3 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.4 | 1.1 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
0.4 | 1.1 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.4 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 1.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 3.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 1.4 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.3 | 1.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.3 | 1.0 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.3 | 1.0 | GO:0043318 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) insulin catabolic process(GO:1901143) |
0.3 | 0.9 | GO:0097187 | dentinogenesis(GO:0097187) |
0.3 | 1.8 | GO:0030421 | defecation(GO:0030421) |
0.3 | 1.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.3 | 0.9 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.3 | 0.9 | GO:0042214 | terpene metabolic process(GO:0042214) phytoalexin metabolic process(GO:0052314) |
0.3 | 1.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.3 | 1.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 0.8 | GO:1900126 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 1.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.3 | 2.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.8 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.3 | 0.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.3 | 0.8 | GO:0043096 | purine nucleobase salvage(GO:0043096) guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 0.3 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.2 | 0.5 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.2 | 0.7 | GO:0014806 | negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
0.2 | 1.2 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 3.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.2 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
0.2 | 0.7 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.2 | 0.5 | GO:0044209 | AMP salvage(GO:0044209) |
0.2 | 0.7 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.7 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.2 | 2.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 1.1 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.2 | 0.9 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.2 | 0.4 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.2 | 0.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.2 | 0.9 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 1.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 2.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.2 | 0.6 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.2 | 2.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 1.0 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.2 | 1.4 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.6 | GO:0048627 | myoblast development(GO:0048627) |
0.2 | 0.4 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.2 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.8 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.2 | 0.6 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.2 | 0.2 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.2 | 0.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.2 | 0.7 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.2 | 0.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.2 | 0.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 0.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 0.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 1.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 0.5 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 0.9 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.2 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 1.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 1.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.7 | GO:0003335 | corneocyte development(GO:0003335) |
0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.7 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.2 | 0.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.2 | 0.5 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.2 | 0.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.2 | 0.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 1.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.5 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.2 | 0.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.6 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.2 | 0.5 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.1 | 1.8 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.6 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.1 | 1.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 0.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.6 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 1.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.7 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 0.6 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.6 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
0.1 | 1.1 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.1 | 0.6 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.1 | 1.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 1.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.1 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.1 | 0.4 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.4 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.1 | 1.0 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.1 | 0.7 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 1.1 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.1 | 0.3 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.1 | 0.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.4 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.1 | 3.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 1.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 1.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.4 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.5 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.2 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
0.1 | 0.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.1 | 1.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.8 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 1.9 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.1 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
0.1 | 0.5 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.5 | GO:0042391 | regulation of membrane potential(GO:0042391) |
0.1 | 1.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.1 | 0.6 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular response to UV-A(GO:0071492) |
0.1 | 0.4 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.1 | 0.3 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.3 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.3 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.1 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 1.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.6 | GO:0022614 | membrane to membrane docking(GO:0022614) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.4 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.1 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.4 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.4 | GO:0060066 | oviduct development(GO:0060066) |
0.1 | 0.5 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 1.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.7 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.8 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.5 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.4 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 1.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.2 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.1 | 2.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.6 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 0.3 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.1 | 1.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.5 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.4 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 2.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.1 | 0.5 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.7 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway(GO:0038094) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.1 | 0.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.4 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.1 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.3 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.1 | 0.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.7 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 1.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.9 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.1 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.1 | 0.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 0.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.7 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.2 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.1 | 0.4 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.3 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.1 | 0.2 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.1 | 1.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 1.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.2 | GO:0021623 | oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.6 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.2 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 2.0 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 1.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.5 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 0.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 1.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.2 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.1 | 0.1 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.1 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.7 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.2 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.1 | 0.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.5 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 0.8 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 1.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.9 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 1.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 2.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 2.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 1.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.2 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 1.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.2 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
0.1 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
0.1 | 0.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.1 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.1 | 0.2 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.3 | GO:1904075 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 0.1 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.7 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 1.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.1 | 0.1 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.1 | 0.2 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.2 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) cellular response to vitamin E(GO:0071306) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.2 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.1 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.4 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.1 | 0.2 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.1 | 0.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.5 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.1 | 1.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.1 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 1.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.2 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 0.4 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.3 | GO:0071362 | cellular response to ether(GO:0071362) |
0.1 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.1 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.1 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.1 | 0.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 0.7 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 1.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.7 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.4 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.2 | GO:1903947 | regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.1 | 0.5 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
0.1 | 0.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.3 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.7 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.2 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 0.1 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.1 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 0.2 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.2 | GO:0044848 | biological phase(GO:0044848) |
0.1 | 0.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.1 | 0.7 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.2 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.0 | 0.1 | GO:0031056 | regulation of histone modification(GO:0031056) |
0.0 | 0.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.0 | 0.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.0 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.2 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.0 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0071029 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.0 | 0.7 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.2 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.0 | 0.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.0 | 0.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.0 | 0.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.0 | 0.1 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.0 | 0.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.4 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.3 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.0 | 0.1 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.0 | 0.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.0 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.0 | 1.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.0 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.0 | 0.1 | GO:1900193 | regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.2 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.0 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 1.7 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.2 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.0 | 0.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.0 | 0.0 | GO:0048806 | genitalia development(GO:0048806) |
0.0 | 0.6 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.0 | 0.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.2 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.5 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.2 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) apoptotic process involved in luteolysis(GO:0061364) |
0.0 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:0019860 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) beta-alanine metabolic process(GO:0019482) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) |
0.0 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.3 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 1.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.2 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) farnesyl diphosphate metabolic process(GO:0045338) |
0.0 | 0.3 | GO:0007626 | locomotory behavior(GO:0007626) |
0.0 | 0.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.1 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.8 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.0 | 0.4 | GO:2000147 | positive regulation of locomotion(GO:0040017) positive regulation of cell motility(GO:2000147) |
0.0 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 1.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.8 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.0 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.1 | GO:0003289 | septum secundum development(GO:0003285) atrial septum primum morphogenesis(GO:0003289) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.5 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.1 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.0 | 0.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.2 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 1.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.1 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.0 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.0 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.0 | 0.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.0 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.0 | 0.2 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.1 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:0003231 | cardiac ventricle development(GO:0003231) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.2 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.4 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.1 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.0 | 0.1 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.0 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.9 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.0 | 0.1 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 3.2 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.7 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.3 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
0.0 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 1.0 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.8 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.0 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.0 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 | 0.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.0 | 0.4 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.3 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.0 | 0.1 | GO:0009635 | response to herbicide(GO:0009635) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.0 | 0.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.6 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.0 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) protein localization to vacuolar membrane(GO:1903778) |
0.0 | 0.1 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.0 | 0.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 0.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.3 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.0 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.2 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.0 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.1 | GO:0051345 | positive regulation of hydrolase activity(GO:0051345) |
0.0 | 1.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.2 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) |
0.0 | 0.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.0 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0046189 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) phenol-containing compound biosynthetic process(GO:0046189) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 1.3 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.2 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.9 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.1 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.0 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.1 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.0 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.2 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0006818 | hydrogen transport(GO:0006818) proton transport(GO:0015992) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.1 | GO:0015862 | uridine transport(GO:0015862) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.0 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.1 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0098704 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 | 0.1 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 0.1 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0071317 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
0.0 | 0.2 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.0 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.0 | 1.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.0 | 0.4 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.0 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.0 | GO:1900180 | regulation of protein localization to nucleus(GO:1900180) |
0.0 | 0.2 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.0 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.4 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.6 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.0 | 0.1 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.3 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 0.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
0.0 | 0.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.0 | GO:0007623 | circadian rhythm(GO:0007623) |
0.0 | 0.4 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.0 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.1 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.5 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.0 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 0.0 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.0 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.0 | 0.3 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.0 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.0 | 0.2 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.0 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.0 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.1 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.0 | 0.0 | GO:0003273 | mitral valve formation(GO:0003192) cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.2 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:1902916 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 8.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.6 | 1.8 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
0.5 | 0.5 | GO:0051286 | cell tip(GO:0051286) |
0.4 | 2.0 | GO:0032449 | CBM complex(GO:0032449) |
0.4 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 2.7 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 1.3 | GO:0045160 | myosin I complex(GO:0045160) |
0.3 | 1.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 1.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.2 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 1.9 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 1.2 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 2.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 0.6 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.5 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 2.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 0.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.5 | GO:0043260 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) laminin-11 complex(GO:0043260) |
0.1 | 0.6 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 1.9 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.5 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 0.3 | GO:0034680 | integrin alpha1-beta1 complex(GO:0034665) integrin alpha3-beta1 complex(GO:0034667) integrin alpha10-beta1 complex(GO:0034680) integrin alpha11-beta1 complex(GO:0034681) |
0.1 | 0.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.1 | 0.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 3.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.4 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 2.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 0.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 1.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.9 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 2.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.1 | 0.7 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 1.5 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.2 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.1 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 1.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.8 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 0.9 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 2.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.0 | 5.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 6.7 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 1.0 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0036452 | ESCRT complex(GO:0036452) |
0.0 | 0.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.0 | 0.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 1.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.0 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 2.9 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 1.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 6.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.4 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 1.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.7 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.3 | GO:0033643 | host cell part(GO:0033643) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.4 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.0 | GO:0031430 | M band(GO:0031430) |
0.0 | 9.5 | GO:0005925 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 2.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 2.1 | GO:0070161 | anchoring junction(GO:0070161) |
0.0 | 0.0 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.0 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 2.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 1.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 3.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.0 | 0.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 1.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.0 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 1.8 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 1.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 1.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.5 | 0.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.5 | 1.8 | GO:0030395 | lactose binding(GO:0030395) |
0.4 | 1.9 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.4 | 3.3 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.3 | 2.1 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.3 | 1.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 1.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 1.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 0.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.0 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.2 | 0.7 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.2 | 4.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.2 | 1.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.2 | 1.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.2 | 1.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 2.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.6 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 0.7 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.2 | 1.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.5 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.2 | 0.7 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 1.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.5 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.2 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 0.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.2 | 1.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.2 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.2 | 0.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.4 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 0.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 1.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 1.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 2.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0032093 | SAM domain binding(GO:0032093) |
0.1 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 2.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.8 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.3 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.1 | 0.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.7 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 1.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.6 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.4 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 2.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 1.1 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 1.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.4 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 0.4 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 2.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.1 | 3.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 1.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.1 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 1.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.2 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 1.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.0 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 1.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 2.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 0.2 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.1 | 0.4 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 8.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.9 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.2 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 2.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) phosphothreonine binding(GO:0050816) |
0.1 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 1.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.3 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.4 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 1.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 1.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.2 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.0 | 0.1 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.0 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 1.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 2.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 0.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.0 | 2.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.0 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.9 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 1.0 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 5.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 3.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.0 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.2 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.0 | 1.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.0 | 0.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 1.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 1.0 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
0.0 | 0.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.0 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 1.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.1 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.0 | 0.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.0 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.0 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.6 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.4 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.0 | 0.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 7.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 2.8 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 1.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.0 | 0.7 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 1.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) ghrelin receptor binding(GO:0031768) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.0 | 0.2 | GO:0005543 | phospholipid binding(GO:0005543) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 3.5 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 1.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 0.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 1.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.0 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.3 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.5 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 5.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.0 | 0.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.0 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
0.0 | 0.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.2 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 1.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 1.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.0 | GO:0017129 | triglyceride binding(GO:0017129) |
0.0 | 0.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 3.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 5.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 3.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 3.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 2.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 2.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 3.2 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 2.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 2.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 7.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 9.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 4.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 3.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 2.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 3.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 4.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 3.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.0 | 2.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 1.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 2.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 1.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 3.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.5 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 1.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 2.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 2.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 3.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 1.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 1.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 2.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.1 | REACTOME SIGNALING BY GPCR | Genes involved in Signaling by GPCR |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 1.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.1 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 0.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |